Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M
Athira Pharma plans to price its stock at $15 to $17 per share and raise up to $170 million in its initial public offering.
The Seattle biotech filed updated IPO paperwork Monday. It will sell 10 million shares and be valued at $480 million at the midpoint of the proposed
This post was originally published on this site